![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig2_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition) Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2444050717300761:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNdvmYPHt6bjyzOpfOlwJvwGBYc//ZwJBYMynuudQpd+r5uPgZn3Bk8bAnXmG/cZzggr8+Nhc/NIJ0RJJbkMNDWz98QaCsdYhUGqRFnAAM+isbIo1ebmdOETlhak8TUYhmbSXaCrOjF/5Gk4czEghiHsxjIwunYUS5qAabn/HLBYApGB3L2Kx9A6c27T0aVXwg7Sy47di7c+El1aVjNgygVGgQJWm7ZX82JA35r+3HjiV33cVfFGppsjlgKnqpk7V+s=)
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)
![Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy | Oncology Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy | Oncology](https://www.frontiersin.org/files/Articles/52319/fonc-03-00155-HTML/image_m/fonc-03-00155-g001.jpg)
Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy | Oncology
![Пакет изследвания за жената /CA 19-9, СА 15-3, СА 125 и СЕА общ туморен маркер/, само за 50 лв от Медикодиагностична лаборатория "Д-р Ноневи" Пакет изследвания за жената /CA 19-9, СА 15-3, СА 125 и СЕА общ туморен маркер/, само за 50 лв от Медикодиагностична лаборатория "Д-р Ноневи"](https://www.omed.bg/images/cache/product/4055_large.jpg)
Пакет изследвания за жената /CA 19-9, СА 15-3, СА 125 и СЕА общ туморен маркер/, само за 50 лв от Медикодиагностична лаборатория "Д-р Ноневи"
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitnxjed-32.jpg)
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
![The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/181/public/181-1293-1-PB.jpg)
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-17175-7/MediaObjects/41598_2017_17175_Fig1_HTML.jpg)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Женско здраве! Пакет изследвания на туморни маркери СА 15-3, CA 125 и CA 19- 9, от Медико-диагностична лаборатория Лина | Grabo Mobile Женско здраве! Пакет изследвания на туморни маркери СА 15-3, CA 125 и CA 19- 9, от Медико-диагностична лаборатория Лина | Grabo Mobile](https://imgrabo.com/pics/deals/15065842941552.jpeg)
Женско здраве! Пакет изследвания на туморни маркери СА 15-3, CA 125 и CA 19- 9, от Медико-диагностична лаборатория Лина | Grabo Mobile
![Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1743919113010789-gr1.jpg)
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
![Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients](https://www.jcancer.org/v09/p0494/jcav09p0494g003.jpg)